Academician
NİLAY ŞAHİN
PROFESÖR
BALIKESİR ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Fiziksel Tıp ve Rehabilitasyon
A quick look at recorded outputs — details below.
- Articles 113
- Projects 0
- Books 0
- Proceedings 0
- Patents 0
- Artistic 0
Scopus (SJR)
Q1
4
Q2
38
Q3
19
Q4
12
WoS (JCR)
Q1
3
Q2
31
Q3
13
Q4
28
TR Index
17
articles
Field+year+type normalized OpenAlex percentiles — not Clarivate ESI / SciVal.
Top 1% articles
0
Top 10% articles
17
Avg percentile
74.4%
Top 1% share
0.0%
Top 10% share
32.1%
Articles
Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.
Article list
- 2025 Comparison of PPD and IGST Sensitivity in Latent Tuberculosis Assessment (Cross-sectional Study) YÖKSİS TR Index OpenAlex 24.1%
- 2025 Low vaccination rates and awareness status in patients with rheumatoid arthritis: a nationwide cross-sectional survey study YÖKSİS SJR Q2 JCR Q2 OpenAlex top 10% OpenAlex 95.4%
- 2025 The Gut-Joint Connection: Microbiome’s Role in Rheumatic Disease YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 64.2%
- 2025 The impact of obesity and overweight on rheumatoid arthritis patients: real-world insights from a biologic and targeted synthetic DMARDs registry YÖKSİS SJR Q2 JCR Q2 OpenAlex top 10% OpenAlex 95.5%
- 2025 Clinical characteristics of peripheral joint disease in axial and peripheral spondyloarthritis: findings from a multicentre cross-sectional study YÖKSİS SJR Q2 JCR Q2 OpenAlex top 10% OpenAlex 92.7%
- 2025 Factors influencing the transition time from psoriasis to psoriatic arthritis: a real-world multicenter analysis YÖKSİS SJR Q2 JCR Q2 OpenAlex 74.9%
- 2025 The impact of obesity and overweight on rheumatoid arthritis patients: real-world insights from a biologic and targeted synthetic DMARDs registry YÖKSİS SJR Q2 JCR Q2 OpenAlex top 10% OpenAlex 95.5%
- 2025 The impact of obesity and overweight on rheumatoid arthritis patients: real-world insights from a biologic and targeted synthetic DMARDs registry YÖKSİS SJR Q2 JCR Q2 OpenAlex 82.8%
- 2024 Diagnostic delay in psoriatic arthritis: insights from a nationwide multicenter study YÖKSİS SJR Q2 JCR Q2 OpenAlex top 10% OpenAlex 93.4%
- 2024 Regional variations in psoriatic arthritis: Insights from a nationwide multicenter analysis in Türkiye YÖKSİS SJR Q3 JCR Q4 OpenAlex 69.5%
- 2023 Correlation of clinical signs and magnetic resonance imaging findings in patients with lumbar spondylosis YÖKSİS SJR Q3 JCR Q4 OpenAlex 44.4%
- 2023 Correlation of clinical signs and magnetic resonance imaging findings in patients with lumbar spondylosis YÖKSİS SJR Q3 JCR Q4 OpenAlex 44.4%
- 2023 The impact of nail psoriasis on disease activity, quality of life, and clinical variables in patients with psoriatic arthritis: A cross‐sectional multicenter study YÖKSİS SJR Q3 JCR Q2 OpenAlex 83.5%
- 2023 Beyond expectations: disease duration and psychological burden in psoriatic arthritis YÖKSİS SJR Q2 JCR Q2 OpenAlex 86.0%
- 2022 The clinical, functional, and radiological features of hand osteoarthritis: TLAR-osteoarthritis multi-center cohort study YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 64.7%
- 2022 The clinical, functional, and radiological features of hand osteoarthritis: TLAR-osteoarthritis multi-center cohort study YÖKSİS SJR Q4 JCR Q4 OpenAlex 64.7%
- 2022 The Impact of Nail Psoriasis on Disease Activity, Quality of Life, and Clinical Variables in Patients with Psoriatic Arthritis: A Cross-Sectional Multicenter Study YÖKSİS SJR Q3 JCR Q3 OpenAlex 83.5%
- 2022 Inconsistencies of the Disease Activity Assessment Tools for Psoriatic Arthritis: Challenges to Rheumatologists YÖKSİS SJR Q2 JCR Q2 OpenAlex 85.8%
- 2022 Evaluation of hepatitis serology and frequency of viral reactivation in patients with inflammatory arthritis receiving biologic agents: a multicenter observational study. YÖKSİS SJR Q2 JCR Q2 OpenAlex 78.1%
- 2022 Evaluation of hepatitis serology and frequency of viral reactivation in patients with inflammatory arthritis receiving biologic agents: a multicenter observational study YÖKSİS SJR Q2 JCR Q2 OpenAlex 78.1%